[Translation] A Phase I Study to Evaluate the Pharmacokinetics and Safety of Olorofim after a Single Oral Dose in Healthy Chinese Subjects
本临床试验的主要目的是在中国健康受试者中评估Olorofim单次口服给药的PK,次要目的是在中国健康受试者中评估Olorofim单次口服给药的安全性和耐受性。
[Translation] The primary objective of this clinical trial is to evaluate the PK of a single oral administration of Olorofim in healthy Chinese subjects, and the secondary objective is to evaluate the safety and tolerability of a single oral administration of Olorofim in healthy Chinese subjects.